Table 1 Description of the study population: 56 male individuals with a history of coronary artery disease.
Clinical Characteristics | Mean (± SD) | |
|---|---|---|
Age [years] | 66 (± 6) | |
Body mass index (BMI) [kg/m2] | 28 (± 4) | |
| Â | Â | Total number N (%) |
History of myocardial infarction | 43 (77) | |
Revascularization (CABG/PTCAa) | 48 (86) | |
Type 2 diabetes mellitus | 12 (21) | |
Hypertensionb | 39 (70) | |
NYHA≥ II | 17 (30) | |
COPD | 5 (9) | |
Occupational status: | - Work part time or full time | 4 (7) |
| Â | - Retired | 49 (88) |
| Â | - Unable to work or unemployed | 3 (5) |
| Â | - Exposed to toxic gases, dust or fumes at work | 1 (2) |
Smoking: | - Never-smoker | 15 (27) |
| Â | - Ex-smoker | 41 (73) |
Medication use: | - Beta-adrenergic receptor blockers | 43 (77) |
| Â | - Anti-arrhythmic therapy | 2 (4) |
| Â | - ACE-inhibitors | 30 (54) |
| Â | - Calcium-blockers | 17 (30) |
| Â | - Nitrates | 24 (43) |
| Â | - Acetylsalicylic acid (aspirin) | 46 (82) |
| Â | - Statins and Fibrates | 29 (52) |